Development

The first gene therapy for genetic hearing loss is approved in 61 days

development2026-04-26

Claim

The FDA approved the first gene therapy for genetic hearing loss just 61 days after filing under its priority voucher programme.

Reported metric: 61 days

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.